Health Care Law Matters Blog

Recent Blog Posts

When Private Equity Comes Calling, Buy Instead

E.J. Cyran, Healthcare Lawyer and Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode may be a surprising one for physicians, dentists and other healthcare providers–when private equity shows interest in your practice or your facility, think about expanding and... Continue Reading…More

Court Vacates CFPB Medical Debt Rule: Key Takeaways for Providers

A recent federal court decision has vacated the CFPB’s Medical Debt Rule, restoring the previous framework under the Fair Credit Reporting Act (FCRA). Credit reporting agencies can continue to include coded medical debt in consumer reports, and creditors may consider this information when making credit decisions. Healthcare providers should ensure compliance with FCRA requirements and stay alert for future regulatory changes, especially as some states continue to pursue their own medical debt reporting laws. Continue Reading…More

Avoiding Landmines in Agreements between Healthcare Providers

E.J. Cyran, Healthcare Lawyer and Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode was identifying and avoiding landmines in agreements between private practices and other healthcare providers. You can listen to the episode on Apple or Spotify here: https://marketvisorygroup.com/podcast/e-j-cyran-on-landmines-in-agreements-with-other-healthcare-providers/ Contact E.J. Cyran at ecyran@foxrothschild.com or (610) 458-4963. Continue Reading…More

End of Semaglutide Shortage Means Big Changes for Prescribers and Compounders

On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for the drug exceeded the available supply. Initially developed and utilized for treatment of Type 2 diabetes, semaglutide and other GLP-1 medications can also result in... Continue Reading…More

How Private Practices Can Avoid Landmines in Vendor Agreements

E.J. Cyran, Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode was identifying and avoiding landmines in agreements between vendors and private practices. You can listen to the episode on Apple or Spotify here: https://marketvisorygroup.com/podcast/ej-cyran-on-landmines-in-vendor-agreements/ Whether you have a medical,... Continue Reading…More

Pennsylvania Limits Non-Competes for Most Health Care Practitioners and Requires Patient Disclosure Upon Departure

Beginning on January 1, 2025, employment-based non-compete covenants will be unenforceable against physicians, certified registered nurse practitioners, physician assistants and certified registered nurse anesthetists (each, a “practitioner”) in Pennsylvania, unless the non-compete covenant is for less than one year in duration and the practitioner was not “dismissed” by the employer. The Fair Contracting for Health... Continue Reading…More

The CFPB’s Continued Spotlight on Medical Debt Emphasizes the Importance of Proper Provider Billing

Last month, the Consumer Financial Protection Bureau (CFPB) issued its 2023 Annual Report on the Fair Debt Collection Practices Act (FDCPA), which notes the CFPB’s activities and observations related to debt collection in 2022. The CFPB is continuing its trend of focusing its attention on medical debt.   The CFPB claims that the collection, furnishing,... Continue Reading…More

The CFPB Considers Rules to Remove Medical Debt from Credit Reports: What does this Mean for Medical and Dental Providers?

Last month, the Consumer Financial Protection Bureau (CFPB) kicked off a rulemaking process that, if enacted, would reshape the credit reporting and debt collection landscape and could have a detrimental effect on medical and dental providers’ bottom line. As we previously noted, the CFPB, under director Rohit Chopra, continues to make medical financing and debt... Continue Reading…More

The CFPB’s Latest Report on Medical Credit Cards Addresses Misleading Activity by Providers.

Federal regulators are focusing in on medical credit cards and financing plans and the roles that healthcare providers have in facilitating them.  The Consumer Financial Protection Bureau (“CFPB”) is a federal agency charged with implementing and enforcing federal consumer financial laws in effort to ensure markets for consumer financial products are fair, transparent, and competitive. ... Continue Reading…More

Are We There Yet? New HIPAA Privacy Protections for Reproductive Health Data May Be Just Ahead

This blog post was first published on the Fox HIPAA & Health Information Technology Blog. It covers a critical new rule proposed by the Office For Civil Rights to close loopholes in HIPAA with respect to reproductive healthcare. For questions or follow-up, please contact Elizabeth Litten, Esq. at elitten@foxrothschild.com. As states enact and enforce various... Continue Reading…More